sarabjit ashta
chief business officer
glycadia pharmaceuticals
Sarabjit is currently chief business officer at Glycadia Pharmaceuticals, a clinical-stage biotech company focused on metabolic conditions, particularly diabetic complications. Its lead program, which is focused on diabetic nephropathy, has successfully completed a Phase IIa trial.
Previously, Sarabjit has held leadership positions spanning corporate/business development and strategic planning at Dr. Reddy’s Laboratories, Endo Pharmaceuticals, Biogen and Becton Dickinson. He also spent a decade as an international investment banker focused on mergers and acquisitions with Sumitomo Bank.
Sarabjit holds an undergraduate degree in mathematical economics and econometrics from the London School of Economics, and an M.B.A. in international finance from New York University, Stern School of Business.
Learn more about Sarabjit: https://www.linkedin.com/in/sarabjit-ashta/